Lymphoma Clinical Trials in Houston

Showing 441-460 of 533 trials

Selumetinib in Treating Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma

NCT01278615

This phase II clinical trial is studying how well selumetinib works in treating patients with relapsed or refractory diffuse large B-cell lymphoma. Selumetinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth.

Recurrent Adult Diffuse Large Cell Lymphoma

National Cancer Institute (NCI)16 participantsStarted Dec 2010

Chicago, Illinois, United States • Chicago, Illinois, United States • Decatur, Illinois, United States +13 more locations

COMPLETEDPhase 2< 1 mile

Study of Total Skin Electron Beam Therapy (TSEBT) in Stage IB-IIIA Mycosis Fungoides

NCT01073267

The goal of this clinical research study is to learn if a lower than standard dose of total skin electron beam radiation therapy to the skin can help to control mycosis fungoides. The safety of this dose level will also be studied.

Lymphoma

M.D. Anderson Cancer Center4 participantsStarted Feb 2010

Houston, Texas, United States

Selumetinib in Treating Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma

Study of Total Skin Electron Beam Therapy (TSEBT) in Stage IB-IIIA Mycosis Fungoides

Lymphoma Trials in Other Cities

Vorinostat With Gemcitabine, Busulfan, and Melphalan With Stem Cell Transplant (SCT) in Relapsed or Refractory Lymphoid Malignancies

Study of YM155 in Refractory Diffuse Large B-cell Lymphoma (DLBCL) Subjects

A Study of XL844 Administered as a Single Agent and in Combination With Gemcitabine in Adults With Advanced Malignancies

A Phase II Clinical Trial of PXD101 in Patients With Recurrent or Refractory Cutaneous and Peripheral T-Cell Lymphomas

Study of MGCD0103 (MG-0103) in Patients With Relapsed or Refractory Hodgkin's Lymphoma

MGCD0103 Administered in Combination With Azacitidine (Vidaza®) to Subjects With Relapsed or Refractory Hodgkin or Non-Hodgkin Lymphoma

Study of MGCD0103 Given Three Times Weekly in Patients With Relapsed and Refractory Lymphoma

Study of Bortezomib in Combination With Cyclophosphamide and Rituximab

Study Evaluating Temsirolimus (CCI-779) In Mantle Cell Lymphoma (MCL)

A Randomized Phase IIb Placebo-Controlled Study of R-ICE Chemotherapy With and Without SGN-40 for Patients With DLBCL

Allo BMT Using Matched Related/Unrelated Donors With FluBu and HiCY

Dasatinib in Treating Patients With Solid Tumors or Lymphomas That Are Metastatic or Cannot Be Removed By Surgery

Phase I/II Study of CAMPATH in Patients With Relapsing or Refractory Non-Hodgkin's Lymphoma

Traumeel® S in Preventing and Treating Mucositis in Young Patients Undergoing Stem Cell Transplantation

A Study of YM155 Plus Rituximab in Subjects With Non-Hodgkin's Lymphoma Who Have Received Prior Treatment

A Study of Rituximab and Bevacizumab in Patients With Follicular Non-Hodgkin's Lymphoma

A Study of Investigational SAR245409 in Patients With Certain Lymphoma or Leukemia

A Study of Ocrelizumab in Participants With Follicular Non-Hodgkin's Lymphoma (NHL)

Other Conditions in Houston